Orthotopic Xenograft Websites
EPO Berlin-Buch GmbH | PDX Model|PDX-Model|From Target identification
Testing in vivo, in vitro, xenograft, orthotopic xenograft, syngeneic and cancer. Based on a more than 15 years experience, EPO offers customized and comprehensive service for the preclinical development of new cancer drugs.
Not Applicable
$
8.95
